EU regulators halt review of Zimmer's $13 billion Biomet bid
BRUSSELS (Reuters) - The European Commission halted its review of Zimmer Holdings Inc's $13.4 billion (7.97 billion pounds) bid for Biomet Inc [LVBHAB.UL] on Thursday, saying the U.S. orthopedic products maker's submission lacked some details.
Zimmer sought European Union clearance on June 3 for the deal that would make it the second-biggest in the sector, behind market leader Johnson & Johnson.
"The notification that the Commission received was incomplete," Commission spokesman for competition policy Antoine Colombanni said.
The watchdog scrapped its July 9 deadline for a decision on the deal and will set a new date once Zimmer provides the required data.
(Reporting by Foo Yun Chee; Editing by Erica Billingham)
